Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1 Gastrointestinal 1 Breast 1

Conditions

Pancreatic Ductal Adenocarcinoma (PDAC) 1

Interventions

Oxaliplatin 137 Fluorouracil 129 Gemcitabine 114 Bevacizumab 111 Specimen Handling 102 Leucovorin 101 Capecitabine 90 Magnetic Resonance Spectroscopy 81 pembrolizumab 79 Cisplatin 75 Nivolumab 72 Irinotecan 68 130-nm albumin-bound paclitaxel 59 durvalumab 58 Cetuximab 58 Paclitaxel 57 Biopsy 56 atezolizumab 42 Radiotherapy 41 Taxes 36 Albumin-Bound Paclitaxel 36 Folfox protocol 34 Carboplatin 34 Cyclophosphamide 29 Drug Therapy 28 lenvatinib 27 tislelizumab 26 sintilimab 26 dehydroftorafur 26 Radiation 26

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

FAPI-46 × Gastrointestinal × 90 days × Clear all

NCT06659705 2026-04-15

INDIGO-FAPI

Institut Curie

Phase 2 Recruiting

Gastrointestinal

Pancreatic Ductal Adenocarcinoma (PDAC)

Data powered by HemOnc (CC BY 4.0) Colophon ⚡